doi : 10.1016/S1936-8798(23)00384-9
Volume 16, Issue 3, 13 February 2023, Pages A1-A4
Bahadir Simsek, MD,a Spyridon Kostantinis, MD,a Judit Karacsonyi, MD, PH D, a Abdul Hakeem, MD,b,c Abhiram Prasad, MD, d Anand Prasad, MD, e Anna E. Bortnick, MD, P HD, MSC ,f,g Basem Elbarouni, MD,h Hani Jneid, MD, i J. Dawn Abbott, MD, j Lorenzo Azzalini, MD, P HD, MSC ,k Louis P. Kohl, MD,l Mario Gössl, MD, PHD, a Rajan A.G. Patel, MD, m Salman Allana, MD, a Tamim M. Nazif, MD, n Usman Baber, MD,o Olga C. Mastrodemos, BA,a Tarek Chami, MD,a Madeline Mahowald, MD,a Athanasios Rempakos, MD,a Bavana V. Rangan, BDS, MPH, a Yader Sandoval, MD, a Emmanouil S. Brilakis, MD, PH D
doi : 10.1016/j.jcin.2022.11.034
Volume 16, Issue 3, 13 February 2023, Pages 247-257
Lloyd W. Klein, MD
doi : 10.1016/j.jcin.2022.12.020
Volume 16, Issue 3, 13 February 2023, Pages 258-260
Adam C. Salisbury, MD, MS C, a,b J. Aaron Grantham, MD,a,b W. Morris Brown, MD,c William L. Ballard, MD, c Keith B. Allen, MD,a,b Ajay J. Kirtane, MD, SM, d Michael Argenziano, MD, d Robert W. Yeh, MD, MS C,e Kamal Khabbaz, MD,e John Lasala, MD,f Puja Kachroo, MD,f Dimitri Karmpaliotis, MD,d Jeffrey Moses, MD,d William L. Lombardi, MD,g Karen Nugent, RRT, a Ziad Ali, MD, d Kensey L. Gosch, MS, a John A. Spertus, MD, MPH,a,b David E. Kandzari, MD, c on behalf of the OPTIMUM Investigators
doi : 10.1016/j.jcin.2023.01.003
Volume 16, Issue 3, 13 February 2023, Pages 261-273
Percutaneous coronary intervention (PCI) is increasingly used to revascularize patients ineligible for CABG, but few studies describe these patients and their outcomes.
John A. Bittl, MD, a Robert L. Feldman, MD
doi : 10.1016/j.jcin.2023.01.014
Volume 16, Issue 3, 13 February 2023, Pages 274-276
Derrick Y. Tam, MD, P HD, a,b Jiming Fang, PHD, c Rodolfo V. Rocha, MD, PHD, d Sunil V. Rao, MD, P HD, e Vladimir Dzavik, MD, P HD, f Jennifer Lawton, MD,g Peter C. Austin, P HD, b,c Mario Gaudino, MD,h Stephen E. Fremes, MD, MS C,a,b Douglas S. Lee, MD, PHD
doi : 10.1016/j.jcin.2022.10.016
Volume 16, Issue 3, 13 February 2023, Pages 277-288
Randomized trials have compared percutaneous coronary intervention and coronary artery bypass grafting (CABG) in patients with left main coronary artery disease undergoing nonemergent revascularization. However, there is a paucity of real-world contemporary observational studies comparing percutaneous coronary intervention (PCI) and CABG.
Milan Milojevic, MD, PHD, MSCE, a,b Aleksandar Nikolic, MD, PHD
doi : 10.1016/j.jcin.2022.11.024
Volume 16, Issue 3, 13 February 2023, Pages 289-291
Eun-Seok Shin, MD, PH D, a Eun Jung Jun, P HD, a Sunwon Kim, MD, PHD, b Bitna Kim, MS, a Tae-Hyun Kim, MD,c Chang-Bae Sohn, MD, c Ae-Young Her, MD, PHD, d Yongwhi Park, MD, P HD, e Jung Rae Cho, MD, P HD, f Young-Hoon Jeong, MD, P HD, g Byung Joo Choi, MD
doi : 10.1016/j.jcin.2022.10.049
Volume 16, Issue 3, 13 February 2023, Pages 292-299
Data on drug-coated balloon (DCB) treatment in the context of multivessel coronary artery disease (CAD) are limited.
Raban V. Jeger, MD
doi : 10.1016/j.jcin.2022.11.006
Volume 16, Issue 3, 13 February 2023, Pages 300-302
Sneha S. Jain, MD, MBA, a Ditian Li, MPH, b Ovidiu Dressler, MD,b Lak Kotinkaduwa, PH D, b Patrick W. Serruys, MD, PH D, c A. Pieter Kappetein, MD, PHD, d Joseph F. Sabik, MD,e Marie-Claude Morice, MD, f John Puskas, MD, g David E. Kandzari, MD,h Dimitri Karmpaliotis, MD, b,i Nicholas J. Lembo, MD, b,i W. Morris Brown III, MD, h Adrian P. Banning, MD, j Gregg W. Stone, MD
doi : 10.1016/j.jcin.2022.10.011
Volume 16, Issue 3, 13 February 2023, Pages 303-313
Eric R. Bates, MD
doi : 10.1016/j.jcin.2022.11.005
Volume 16, Issue 3, 13 February 2023, Pages 314-316
Grigorios Korosoglou, MD,a Andrej Schmidt, MD, b Michael Lichtenberg, MD,c Giovanni Torsello, MD,d Gerd Grözinger, MD, e Jihad Mustapha, MD, f Ramon L. Varcoe, MD,g Thomas Zeller, MD,h Erwin Blessing, MD,i Ralf Langhoff, MD
doi : 10.1016/j.jcin.2022.11.036
Volume 16, Issue 3, 13 February 2023, Pages 317-331
A crossing algorithm was developed for the endovascular treatment of peripheral chronic total occlusive lesions (CTOs) to educate, guide, and appropriately influence clinical practice aiming at harmonization and standardization of endovascular procedures.
Kim G. Smolderen, PH D, a,b Gaëlle Romain, P HD, a Jeremy B. Provance, PH D, a Lindsey E. Scierka, MD, MPH,a Jialin Mao, MD, MS C,c Phillip P. Goodney, MD,d Peter K. Henke, MD,e Art Sedrakyan, MD, PHD, c Carlos Mena-Hurtado, MD
doi : 10.1016/j.jcin.2022.09.022
Volume 16, Issue 3, 13 February 2023, Pages 332-343
Lack of guideline-directed medical therapy (GDMT) in patients undergoing peripheral vascular interventions (PVIs) may increase mortality and amputation risk.
Connie N. Hess, MD, MHS, Marc P. Bonaca, MD, MPH
doi : 10.1016/j.jcin.2022.10.015
Volume 16, Issue 3, 13 February 2023, Pages 344-346
Takashige Sakio, MD, Yasuyuki Egami, MD, Hitoshi Nakamura, MD, Yasuharu Matsunaga-Lee, MD, Masamichi Yano, MD, P HD, Masami Nishino, MD, PH D, Jun Tanouchi, MD, PHD
doi : 10.1016/j.jcin.2022.10.033
Volume 16, Issue 3, 13 February 2023, Pages 347-348
Tetsuya Yamamoto, MD,a Takayoshi Toba, MD, PHD, b Toshimitsu Ishii, MD, a Akihiko Ishida, MD, PHD
doi : 10.1016/j.jcin.2022.11.008
Volume 16, Issue 3, 13 February 2023, Pages 349-351
Salvatore Colangelo, MD,a Francesco Colombo, MD, a Mario Iannaccone, MD, a Giacomo Giovanni Boccuzzi, MD,a Kambis Mashayekhi, MD
doi : 10.1016/j.jcin.2022.11.033
Volume 16, Issue 3, 13 February 2023, Pages 352-353
Karen W. Chau, BA, a,b Evan S. Shlofmitz, DO, a Allen Jeremias, MD, MS C,a Richard A. Shlofmitz, MD, a Ziad A. Ali, MD, DPHIL
doi : 10.1016/j.jcin.2022.11.020
Volume 16, Issue 3, 13 February 2023, Pages 354-356
Zhanying Han, MD, Yongjian Zhu, MD, Wenjie Lu, MD, Chunguang Qiu, MD
doi : 10.1016/j.jcin.2022.11.026
Volume 16, Issue 3, 13 February 2023, Pages 357-358
Anastasios Apostolos, MD Maria Drakopoulou, MD, PhD Stamatios Gregoriou, MD, PhD Costas Tsioufis, MD, PhD *Konstantinos Toutouzas, MD, PhD
doi : 10.1016/j.jcin.2022.12.004
Volume 16, Issue 3, 13 February 2023, Page 359
Federico Fortuni, MD Giuseppe Ciliberti, MD, PhD Filippo Zilio, MD
doi : 10.1016/j.jcin.2022.12.007
Volume 16, Issue 3, 13 February 2023, Page 360
Paul Guedeney, MD Mikael Laredo, MD Michel Zeitouni, MD, PhD *Gilles Montalescot, MD, PhD
doi : 10.1016/j.jcin.2023.01.001
Volume 16, Issue 3, 13 February 2023, Pages 360-361
Xuzhi Liang, MD *Jijia Li, MD
doi : 10.1016/j.jcin.2022.11.017
Volume 16, Issue 3, 13 February 2023, Pages 361-362
Maria V. Manzi, MD, PhD Stefan James, MD, PhD Giovanna Sarno, MD, PhD Sergio Buccheri, MD
doi : 10.1016/j.jcin.2022.12.017
Volume 16, Issue 3, 13 February 2023, Pages 362-363
Pier Pasquale Leone, MD Antonio Mangieri, MD Damiano Regazzoli, MD Alessandra Laricchia, MD Arif Khokhar, MD Marco Luciano Rossi, MD Azeem Latib, MB BCh Bernhard Reimers, MD *Antonio Colombo, MD
doi : 10.1016/j.jcin.2022.09.054
Volume 16, Issue 3, 13 February 2023, Pages 363-365
Fotios I. Economou, MD, PhD Ioannis Doundoulakis, MD Iliada Kalamakidou, BSN Leonidas Koliastasis, MD Stergios Soulaidopoulos, MD, PhD Myrto Samara, MD, PhD Kyriakos Dimitriadis, MD, PhD Georgios Papazisis, MD, PhD Dimitris Tsiachris, MD, PhD Konstantinos Tsioufis, MD, PhD
doi : 10.1016/j.jcin.2022.09.032
Volume 16, Issue 3, 13 February 2023, Pages 365-367
Karl Fengler, MD Karl-Philipp Rommel, MD Wenzel Kriese, BSc Stephan Blazek, MD Christian Besler, MD Maximilian von Roeder, MD Steffen Desch, MD Holger Thiele, MD Philipp Lurz, MD, PhD
doi : 10.1016/j.jcin.2022.10.058
Volume 16, Issue 3, 13 February 2023, Pages 367-369
doi : 10.1016/S1936-8798(23)00383-7
Volume 16, Issue 3, 13 February 2023, Pages I-CXXVII
doi : 10.1016/S1936-8798(23)00384-9
Volume 16, Issue 3, 13 February 2023, Pages A1-A4
Bahadir Simsek, MD,a Spyridon Kostantinis, MD,a Judit Karacsonyi, MD, PH D, a Abdul Hakeem, MD,b,c Abhiram Prasad, MD, d Anand Prasad, MD, e Anna E. Bortnick, MD, P HD, MSC ,f,g Basem Elbarouni, MD,h Hani Jneid, MD, i J. Dawn Abbott, MD, j Lorenzo Azzalini, MD, P HD, MSC ,k Louis P. Kohl, MD,l Mario Gössl, MD, PHD, a Rajan A.G. Patel, MD, m Salman Allana, MD, a Tamim M. Nazif, MD, n Usman Baber, MD,o Olga C. Mastrodemos, BA,a Tarek Chami, MD,a Madeline Mahowald, MD,a Athanasios Rempakos, MD,a Bavana V. Rangan, BDS, MPH, a Yader Sandoval, MD, a Emmanouil S. Brilakis, MD, PH D
doi : 10.1016/j.jcin.2022.11.034
Volume 16, Issue 3, 13 February 2023, Pages 247-257
Lloyd W. Klein, MD
doi : 10.1016/j.jcin.2022.12.020
Volume 16, Issue 3, 13 February 2023, Pages 258-260
Adam C. Salisbury, MD, MS C, a,b J. Aaron Grantham, MD,a,b W. Morris Brown, MD,c William L. Ballard, MD, c Keith B. Allen, MD,a,b Ajay J. Kirtane, MD, SM, d Michael Argenziano, MD, d Robert W. Yeh, MD, MS C,e Kamal Khabbaz, MD,e John Lasala, MD,f Puja Kachroo, MD,f Dimitri Karmpaliotis, MD,d Jeffrey Moses, MD,d William L. Lombardi, MD,g Karen Nugent, RRT, a Ziad Ali, MD, d Kensey L. Gosch, MS, a John A. Spertus, MD, MPH,a,b David E. Kandzari, MD, c on behalf of the OPTIMUM Investigators
doi : 10.1016/j.jcin.2023.01.003
Volume 16, Issue 3, 13 February 2023, Pages 261-273
Percutaneous coronary intervention (PCI) is increasingly used to revascularize patients ineligible for CABG, but few studies describe these patients and their outcomes.
John A. Bittl, MD, a Robert L. Feldman, MD
doi : 10.1016/j.jcin.2023.01.014
Volume 16, Issue 3, 13 February 2023, Pages 274-276
Derrick Y. Tam, MD, P HD, a,b Jiming Fang, PHD, c Rodolfo V. Rocha, MD, PHD, d Sunil V. Rao, MD, P HD, e Vladimir Dzavik, MD, P HD, f Jennifer Lawton, MD,g Peter C. Austin, P HD, b,c Mario Gaudino, MD,h Stephen E. Fremes, MD, MS C,a,b Douglas S. Lee, MD, PHD
doi : 10.1016/j.jcin.2022.10.016
Volume 16, Issue 3, 13 February 2023, Pages 277-288
Randomized trials have compared percutaneous coronary intervention and coronary artery bypass grafting (CABG) in patients with left main coronary artery disease undergoing nonemergent revascularization. However, there is a paucity of real-world contemporary observational studies comparing percutaneous coronary intervention (PCI) and CABG.
Milan Milojevic, MD, PHD, MSCE, a,b Aleksandar Nikolic, MD, PHD
doi : 10.1016/j.jcin.2022.11.024
Volume 16, Issue 3, 13 February 2023, Pages 289-291
Eun-Seok Shin, MD, PH D, a Eun Jung Jun, P HD, a Sunwon Kim, MD, PHD, b Bitna Kim, MS, a Tae-Hyun Kim, MD,c Chang-Bae Sohn, MD, c Ae-Young Her, MD, PHD, d Yongwhi Park, MD, P HD, e Jung Rae Cho, MD, P HD, f Young-Hoon Jeong, MD, P HD, g Byung Joo Choi, MD
doi : 10.1016/j.jcin.2022.10.049
Volume 16, Issue 3, 13 February 2023, Pages 292-299
Data on drug-coated balloon (DCB) treatment in the context of multivessel coronary artery disease (CAD) are limited.
Raban V. Jeger, MD
doi : 10.1016/j.jcin.2022.11.006
Volume 16, Issue 3, 13 February 2023, Pages 300-302
Sneha S. Jain, MD, MBA, a Ditian Li, MPH, b Ovidiu Dressler, MD,b Lak Kotinkaduwa, PH D, b Patrick W. Serruys, MD, PH D, c A. Pieter Kappetein, MD, PHD, d Joseph F. Sabik, MD,e Marie-Claude Morice, MD, f John Puskas, MD, g David E. Kandzari, MD,h Dimitri Karmpaliotis, MD, b,i Nicholas J. Lembo, MD, b,i W. Morris Brown III, MD, h Adrian P. Banning, MD, j Gregg W. Stone, MD
doi : 10.1016/j.jcin.2022.10.011
Volume 16, Issue 3, 13 February 2023, Pages 303-313
Eric R. Bates, MD
doi : 10.1016/j.jcin.2022.11.005
Volume 16, Issue 3, 13 February 2023, Pages 314-316
Grigorios Korosoglou, MD,a Andrej Schmidt, MD, b Michael Lichtenberg, MD,c Giovanni Torsello, MD,d Gerd Grözinger, MD, e Jihad Mustapha, MD, f Ramon L. Varcoe, MD,g Thomas Zeller, MD,h Erwin Blessing, MD,i Ralf Langhoff, MD
doi : 10.1016/j.jcin.2022.11.036
Volume 16, Issue 3, 13 February 2023, Pages 317-331
A crossing algorithm was developed for the endovascular treatment of peripheral chronic total occlusive lesions (CTOs) to educate, guide, and appropriately influence clinical practice aiming at harmonization and standardization of endovascular procedures.
Kim G. Smolderen, PH D, a,b Gaëlle Romain, P HD, a Jeremy B. Provance, PH D, a Lindsey E. Scierka, MD, MPH,a Jialin Mao, MD, MS C,c Phillip P. Goodney, MD,d Peter K. Henke, MD,e Art Sedrakyan, MD, PHD, c Carlos Mena-Hurtado, MD
doi : 10.1016/j.jcin.2022.09.022
Volume 16, Issue 3, 13 February 2023, Pages 332-343
Lack of guideline-directed medical therapy (GDMT) in patients undergoing peripheral vascular interventions (PVIs) may increase mortality and amputation risk.
Connie N. Hess, MD, MHS, Marc P. Bonaca, MD, MPH
doi : 10.1016/j.jcin.2022.10.015
Volume 16, Issue 3, 13 February 2023, Pages 344-346
Takashige Sakio, MD, Yasuyuki Egami, MD, Hitoshi Nakamura, MD, Yasuharu Matsunaga-Lee, MD, Masamichi Yano, MD, P HD, Masami Nishino, MD, PH D, Jun Tanouchi, MD, PHD
doi : 10.1016/j.jcin.2022.10.033
Volume 16, Issue 3, 13 February 2023, Pages 347-348
Tetsuya Yamamoto, MD,a Takayoshi Toba, MD, PHD, b Toshimitsu Ishii, MD, a Akihiko Ishida, MD, PHD
doi : 10.1016/j.jcin.2022.11.008
Volume 16, Issue 3, 13 February 2023, Pages 349-351
Salvatore Colangelo, MD,a Francesco Colombo, MD, a Mario Iannaccone, MD, a Giacomo Giovanni Boccuzzi, MD,a Kambis Mashayekhi, MD
doi : 10.1016/j.jcin.2022.11.033
Volume 16, Issue 3, 13 February 2023, Pages 352-353
Karen W. Chau, BA, a,b Evan S. Shlofmitz, DO, a Allen Jeremias, MD, MS C,a Richard A. Shlofmitz, MD, a Ziad A. Ali, MD, DPHIL
doi : 10.1016/j.jcin.2022.11.020
Volume 16, Issue 3, 13 February 2023, Pages 354-356
Zhanying Han, MD, Yongjian Zhu, MD, Wenjie Lu, MD, Chunguang Qiu, MD
doi : 10.1016/j.jcin.2022.11.026
Volume 16, Issue 3, 13 February 2023, Pages 357-358
Anastasios Apostolos, MD Maria Drakopoulou, MD, PhD Stamatios Gregoriou, MD, PhD Costas Tsioufis, MD, PhD *Konstantinos Toutouzas, MD, PhD
doi : 10.1016/j.jcin.2022.12.004
Volume 16, Issue 3, 13 February 2023, Page 359
Federico Fortuni, MD Giuseppe Ciliberti, MD, PhD Filippo Zilio, MD
doi : 10.1016/j.jcin.2022.12.007
Volume 16, Issue 3, 13 February 2023, Page 360
Paul Guedeney, MD Mikael Laredo, MD Michel Zeitouni, MD, PhD *Gilles Montalescot, MD, PhD
doi : 10.1016/j.jcin.2023.01.001
Volume 16, Issue 3, 13 February 2023, Pages 360-361
Xuzhi Liang, MD *Jijia Li, MD
doi : 10.1016/j.jcin.2022.11.017
Volume 16, Issue 3, 13 February 2023, Pages 361-362
Maria V. Manzi, MD, PhD Stefan James, MD, PhD Giovanna Sarno, MD, PhD Sergio Buccheri, MD
doi : 10.1016/j.jcin.2022.12.017
Volume 16, Issue 3, 13 February 2023, Pages 362-363
Pier Pasquale Leone, MD Antonio Mangieri, MD Damiano Regazzoli, MD Alessandra Laricchia, MD Arif Khokhar, MD Marco Luciano Rossi, MD Azeem Latib, MB BCh Bernhard Reimers, MD *Antonio Colombo, MD
doi : 10.1016/j.jcin.2022.09.054
Volume 16, Issue 3, 13 February 2023, Pages 363-365
Fotios I. Economou, MD, PhD Ioannis Doundoulakis, MD Iliada Kalamakidou, BSN Leonidas Koliastasis, MD Stergios Soulaidopoulos, MD, PhD Myrto Samara, MD, PhD Kyriakos Dimitriadis, MD, PhD Georgios Papazisis, MD, PhD Dimitris Tsiachris, MD, PhD Konstantinos Tsioufis, MD, PhD
doi : 10.1016/j.jcin.2022.09.032
Volume 16, Issue 3, 13 February 2023, Pages 365-367
Karl Fengler, MD Karl-Philipp Rommel, MD Wenzel Kriese, BSc Stephan Blazek, MD Christian Besler, MD Maximilian von Roeder, MD Steffen Desch, MD Holger Thiele, MD Philipp Lurz, MD, PhD
doi : 10.1016/j.jcin.2022.10.058
Volume 16, Issue 3, 13 February 2023, Pages 367-369
doi : 10.1016/S1936-8798(23)00383-7
Volume 16, Issue 3, 13 February 2023, Pages I-CXXVII
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟